Eyewire News: The Podcast
de Eyewire News
Ophthalmic Executives Provide Company Updates (Part 1 of 2)
Despre acest podcast
Eyewire News: The Podcast keeps listeners updated with the latest information in the ophthalmic field, featuring breaking news from press releases, medical journals, vision publications, and other news sources.
Episoade
Cele mai noi 20 din 114 episoade
- Ophthalmic Executives Provide Company Updates (Part 1 of 2) · 19 minLeaders of several thalamic companies provide updates on their pipeline and new products in the special edition of Eyewire News the Podcast. Learn more about your ad choices…
- Breaking News From the AAO Annual Meeting in New Orleans (Part 2 of 2) · 13 minEyewire News the Podcast reports on new products and breaking news live from thee American Academy of Ophthalmology meeting in New Orleans. Learn more about your ad choices…
- Breaking News From the AAO Annual Meeting in New Orleans (Part 1 of 2) · 10 minEyewire News the Podcast reports on new products and breaking news live from thee American Academy of Ophthalmology meeting in New Orleans. Learn more about your ad choices…
- Special Report: Potential of Robotic Cataract Surgery · 9 minLeaders pioneering fully robotic assisted cataract surgery, discussed the technology and shared their experience treating the first human patients. Learn more about your ad…
- Kodiak Plans to Submit BLA for Zenkuda After Phase 3 Data · 7 minKodiak Sciences meets its primary endpoint in a phase 3 trial for its DME drug candidate clearing the way for a regulatory submission; the European Commission approves Roche’s…
- Breaking News From the ESCRS Congress in London (Part 2 of 2) · 9 minEyewireTV reports on new products and breaking news live from the ESCRS Congress in London. Learn more about your ad choices. Visit megaphone.fm/adchoices
- Breaking News From the ESCRS Congress in London (Part 1 of 2) · 11 minEyewireTV reports on new products and breaking news live from the ESCRS Congress in London. Learn more about your ad choices. Visit megaphone.fm/adchoices
- FDA Accepts Nanoscopes's Optogenetic Gene Therapy BLA · 5 minThe FDA accepts a biologics license application (BLA) for a first-of-its-kind optogenetic gene therapy for RP; a software upgrade from Heru combines several pretesting…
- FDA Sets PDUFA Date for Investigational Glaucoma Eye Drop · 6 minThe FDA accepts Nicox’s NDA for an investigational glaucoma drop; Bausch + Lomb provides updates on two key investigational therapies for dry eye and ocular surface pain; and…
- EyePoint Misses Primary Endpoint in Phase 3 Trial But Sees Promise After Analysis · 6 minEyepoint Pharmaceuticals releases key phase 3 data for its wet AMD drug Duravyu; Zeiss receives FDA clearance for a cloud- and browser-based data management solution; and the FDA…
- Three Major Acquisitions Announced in Ophthalmology · 6 minTarsus Pharmaceuticals enters into a definitive agreement to acquire Alkeus Pharmaceuticals; Harrow acquires dry eye disease nasal spray Tyrvaya from Viatris; and Italy-based…
- Biocon Launches Eylea Biosimilar Yesafili · 4 minAn interchangeable biosimilar to Eylea is launched in the US; patient enrollment is completed in two global phase 3 clinical trials evaluating Duravyu for diabetic macular edema…
- FDA Approves Outlook's Lytenava for Wet AMD · 12 minThe CEO of Outlook Therapeutics discusses the FDA approval of wet AMD drug Lytenava; Roche receives a major boost in its efforts to commercialize wet AMD treatment Susvimo in…
- PRIMA Retinal Implant Launched in EU · 6 minA retinal implant system allowing patients with GA to regain some functional central vision vison is approved in Europe; Bausch + Lomb launches a new preloaded IOL delivery…
- Tarsus Buys Investigational Ocular Antiseptic · 6 minTarsus acquires the maker of an investigational ocular antiseptic; Alcon and RxSight partner to jointly develop adjustable PCIOLs; and the FDA will hold a meeting to discuss…
- Viridian Executive Discusses FDA Approval of New TED Therapy · 14 minAn executive from Viridian discusses the FDA approval of Lumvoa for thyroid eye disease (TED); a biosimilar referencing Lucentis is relaunched in the US; and Lumibird introduces…
- Ocular Updates Plans for Axpaxli NDA for Wet AMD · 7 minOcular Therapeutix provides a key update on its NDA plans for wet AMD drug candidate Axpaxli; Thea US launches a first-of-its-kind eye gel for glaucoma; and there were several…
- Tecnis PureSee IOL Fully Launched in the US · 7 minJohnson & Johnson expands the availability of its latest Tecnis lens; Bayer completes its acquisition of Perfuse Therapeutics, expanding its presence in ophthalmology; and…
- Study Examines Semaglutide and Wet AMD Risk · 5 minAn international study examines the link between a popular weight loss medication and wet AMD risk; Heidelberg receives FDA clearance for a Spectralis software upgrade; and…
- Oculis Announces Phase 3 Results for DME Eye Drops · 5 minOculis Releases phase 3 data for its investigational eye drop for DME; Rayner expands its surgical offerings with the launch of a new OVD; and a biosimilar referencing Eylea is…








